{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:00:51Z","timestamp":1784775651156,"version":"3.55.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.juro.2013.12.005","type":"journal-article","created":{"date-parts":[[2013,12,11]],"date-time":"2013-12-11T19:33:49Z","timestamp":1386790429000},"page":"1743-1748","source":"Crossref","is-referenced-by-count":95,"title":["Urinary PCA3 as a Predictor of Prostate Cancer in a Cohort of 3,073 Men Undergoing Initial Prostate Biopsy"],"prefix":"10.1097","volume":"191","author":[{"given":"K. Kent","family":"Chevli","sequence":"first","affiliation":[{"name":"Department of Urology, University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, New York"},{"name":"Western New York Urology Associates, LLC, Cheektowaga, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Duff","sequence":"additional","affiliation":[{"name":"Department of Urology, University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, New York"},{"name":"Western New York Urology Associates, LLC, Cheektowaga, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Walter","sequence":"additional","affiliation":[{"name":"Department of Urology, University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, New York"},{"name":"Western New York Urology Associates, LLC, Cheektowaga, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhong","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Capuder","sequence":"additional","affiliation":[{"name":"Department of Urology, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Elshafei","sequence":"additional","affiliation":[{"name":"Department of Urology, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Malczewski","sequence":"additional","affiliation":[{"name":"Department of Urology, University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, New York"},{"name":"Western New York Urology Associates, LLC, Cheektowaga, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Kattan","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Stephen","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Urology, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2013.12.005_bib1","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","article-title":"Mortality results from a randomized prostate-cancer screening trial","volume":"360","author":"Andriole","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2013.12.005_bib2","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJMe0901166","article-title":"Screening for prostate cancer\u2013the controversy that refuses to die","volume":"360","author":"Barry","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2013.12.005_bib3","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1113135","article-title":"Prostate cancer mortality at 11 years of follow-up","volume":"366","author":"Schroder","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2013.12.005_bib4","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S1470-2045(10)70146-7","article-title":"Mortality results from the G\u00f6teborg randomised population-based prostate-cancer screening trial","volume":"11","author":"Hugosson","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.juro.2013.12.005_bib5","first-page":"5975","article-title":"DD3: a new prostate-specific gene, highly overexpressed in prostate cancer","volume":"59","author":"Bussemakers","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2013.12.005_bib6","first-page":"2695","article-title":"DD3(PCA3), a very sensitive and specific marker to detect prostate tumors","volume":"62","author":"de Kok","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2013.12.005_bib7","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.juro.2010.06.098","article-title":"PCA3 molecular urine test for predicting repeat prostate biopsy outcome in populations at risk: validation in the placebo arm of the dutasteride REDUCE trial","volume":"184","author":"Aubin","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.12.005_bib8","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.urology.2006.12.014","article-title":"PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy","volume":"69","author":"Marks","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.juro.2013.12.005_bib9","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.juro.2011.01.075","article-title":"Clinical evaluation of the PCA3 assay in guiding initial biopsy decisions","volume":"185","author":"de la Taille","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.12.005_bib10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1442-2042.2010.02711.x","article-title":"Prostate cancer gene 3 urine assay for prostate cancer in Japanese men undergoing prostate biopsy","volume":"18","author":"Ochiai","year":"2011","journal-title":"Int J Urol"},{"key":"10.1016\/j.juro.2013.12.005_bib11","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.juro.2008.01.013","article-title":"PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance","volume":"179","author":"Nakanishi","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.12.005_bib12","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.eururo.2010.11.044","article-title":"Prostate cancer antigen 3 score accurately predicts tumour volume and might help in selecting prostate cancer patients for active surveillance","volume":"59","author":"Ploussard","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2013.12.005_bib13","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.juro.2010.11.072","article-title":"Urinary PCA3 score predicts prostate cancer multifocality","volume":"185","author":"Vlaeminck-Guillem","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.12.005_bib14","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.juro.2008.07.060","article-title":"PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume","volume":"180","author":"Whitman","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.12.005_bib15","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.juro.2007.11.038","article-title":"PCA3: a molecular urine assay for predicting prostate biopsy outcome","volume":"179","author":"Deras","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.12.005_bib16","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.eururo.2008.06.071","article-title":"Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy","volume":"54","author":"Haese","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2013.12.005_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"issue":"suppl.","key":"10.1016\/j.juro.2013.12.005_bib18","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.juro.2007.03.135","article-title":"Contemporary trends in low risk prostate cancer: risk assessment and treatment","volume":"178","author":"Cooperberg","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.12.005_bib19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/pros.21032","article-title":"Predictive value of PCA3 in urinary sediments in determining clinico-pathologic characteristics of prostate cancer","volume":"70","author":"Hessels","year":"2010","journal-title":"Prostate"},{"key":"10.1016\/j.juro.2013.12.005_bib20","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.eururo.2009.03.029","article-title":"Prostate cancer gene 3 (PCA3): development and internal validation of a novel biopsy nomogram","volume":"56","author":"Chun","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2013.12.005_bib21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.eururo.2010.10.024","article-title":"Critical assessment of preoperative urinary prostate cancer antigen 3 on the accuracy of prostate cancer staging","volume":"59","author":"Auprich","year":"2011","journal-title":"Eur Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534713060874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534713060874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2013.12.005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T03:25:35Z","timestamp":1651202735000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2013.12.005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["10.1016\/j.juro.2013.12.005"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2013.12.005","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}